Skip to Main Content

Author Details

Alwin G Schuller
Oncology R&D
2007
11
7
PMIDPaper TitleJournal TitlePublished Year
36912782Novel Arginase Inhibitor, AZD0011, Demonstrates Immune Cell Stimulation and Antitumor Efficacy with Diverse Combination Partners.Mol Cancer Ther2023
37553182Defining the spatial distribution of extracellular adenosine revealed a myeloid-dependent immunosuppressive microenvironment in pancreatic ductal adenocarcinoma.J Immunother Cancer2023
36888921Pharmacokinetic/Pharmacodynamic Analysis of Savolitinib plus Osimertinib in an EGFR Mutation-Positive, MET-Amplified Non-Small Cell Lung Cancer Model.Mol Cancer Ther2023
34890209Quantitative Evaluation of Dendritic Nanoparticles in Mice: Biodistribution Dynamics and Downstream Tumor Efficacy Outcomes.Mol Pharm2022
34516823Oncogenic switch and single-agent MET inhibitor sensitivity in a subset of <i>EGFR</i>-mutant lung cancer.Sci Transl Med2021
33495510Design and optimisation of dendrimer-conjugated Bcl-2/x<sub>L</sub> inhibitor, AZD0466, with improved therapeutic index for cancer therapy.Commun Biol2021
32409420Conversion of ATP to adenosine by CD39 and CD73 in multiple myeloma can be successfully targeted together with adenosine receptor A2A blockade.J Immunother Cancer2020
32988967AZD4320, A Dual Inhibitor of Bcl-2 and Bcl-x<sub>L</sub>, Induces Tumor Regression in Hematologic Cancer Models without Dose-limiting Thrombocytopenia.Clin Cancer Res2020
32727810Small molecule AZD4635 inhibitor of A<sub>2A</sub>R signaling rescues immune cell function including CD103<sup>+</sup> dendritic cells enhancing anti-tumor immunity.J Immunother Cancer2020
30498064Biomarker-driven strategy for MCL1 inhibition in T-cell lymphomas.Blood2019
17929885Global profiling of phosphopeptides by titania affinity enrichment.J Proteome Res2007
  • 1 - 11 of 11

Recommended Authors

Australia Central Clinical School, Monash University
Career Start Year 2014
Number of shared co-authors 0
Baptist Cancer Center
Career Start Year 2013
Number of shared co-authors 0
National Cancer Institute, National Institutes of Health
Career Start Year 2013
Number of shared co-authors 2
Cellworks Group Inc.
Career Start Year 2011
Number of shared co-authors 2
Siteman Cancer Center, Washington University School of Medicine
Career Start Year 2009
Number of shared co-authors 1
UCSF Helen Diller Comprehensive Cancer Center
Career Start Year 2009
Number of shared co-authors 0
Oncology Center of Excellence
Career Start Year 2008
Number of shared co-authors 1
Goldfinch Bio Inc.
Career Start Year 2007
Number of shared co-authors 1
Englander Institute for Precision Medicine
Career Start Year 2007
Number of shared co-authors 0
Ontario Institute for Cancer Research, University Avenue
Career Start Year 2007
Number of shared co-authors 0
The University of Texas MD Anderson Cancer Center
Career Start Year 2006
Number of shared co-authors 1
David Geffen School of Medicine, University of California Los Angeles
Career Start Year 2005
Number of shared co-authors 1
The University of Texas MD Anderson Cancer Center
Career Start Year 2005
Number of shared co-authors 0
University of California san francisco
Career Start Year 2003
Number of shared co-authors 0
Novartis Institutes for BioMedical Research
Career Start Year 2003
Number of shared co-authors 2
MD Anderson Cancer Center
Career Start Year 2003
Number of shared co-authors 0
Netherlands Cancer Institute-Antoni Van Leeuwenhoek
Career Start Year 2003
Number of shared co-authors 0
Roche Pharma Research and Early Development, F. Hoffmann-La Roche Ltd.
Career Start Year 2002
Number of shared co-authors 0
Peter MacCallum Cancer Centre
Career Start Year 2000
Number of shared co-authors 3
Brody School of Medicine, East Carolina University
Career Start Year 1997
Number of shared co-authors 1
University Hospital of Schleswig-Holstein
Career Start Year 1997
Number of shared co-authors 2
University of California Davis Comprehensive Cancer Center
Career Start Year 1996
Number of shared co-authors 1
Children's Cancer Institute, Lowy Cancer Research Centre, School of Clinical Medicine
Career Start Year 1996
Number of shared co-authors 0
Princess Margaret Cancer Centre, University Ave
Career Start Year 1995
Number of shared co-authors 1
University of Colorado Anschutz Medical Campus
Career Start Year 1995
Number of shared co-authors 0
Ohio State University
Career Start Year 1994
Number of shared co-authors 2
David Geffen School of Medicine at university of california los angeles
Career Start Year 1991
Number of shared co-authors 0
Memorial Sloan Kettering Cancer Center
Career Start Year 1989
Number of shared co-authors 1
Yale School of Medicine
Career Start Year 1984
Number of shared co-authors 1
University of Colorado School of Medicine
Career Start Year 1974
Number of shared co-authors 0

Collaborators

Oncology R&D
Co-authored papers 4
Oncology R&D
Co-authored papers 4
Oncology R&D
Co-authored papers 3
Oncology R&D
Co-authored papers 3
Preclinical and Translational Sciences, Inc.
Co-authored papers 3
Oncology R&D
Co-authored papers 3
Oncology R&D
Co-authored papers 2
Oncology R&D
Co-authored papers 2
Oncology R&D
Co-authored papers 2
Oncology R&D
Co-authored papers 2
Oncology R&D
Co-authored papers 2
Oncology R&D
Co-authored papers 2
Oncology R&D
Co-authored papers 2
School of Clinical Sciences at Monash Health, Monash University
Co-authored papers 1
Dana-Farber Cancer Institute
Co-authored papers 1
Oncology R&D
Co-authored papers 1
Oncology R&D
Co-authored papers 1
Oncology R&D
Co-authored papers 1
Oncology R&D
Co-authored papers 1
Co-authored papers 1
Oregon Health & Science University, University of California Berkeley
Co-authored papers 1
Wellcome Sanger Institute
Co-authored papers 1
Co-authored papers 1
H3 Biomedicine Inc.
Co-authored papers 1
Merck & Co.
Co-authored papers 1
Oncology R&D
Co-authored papers 1
Oncology R&D
Co-authored papers 1
The University of Melbourne
Co-authored papers 1
Oncology R&D
Co-authored papers 1
Boston Children's Hospital, Harvard Medical School
Co-authored papers 1